ResearcherThomas Jefferson UniversityActive in the last 2 years
Atrayee Basu Mallick
Matched on ORCID iD 0000-0003-2490-3004; OpenAlex author ID A5062273071. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 1, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 25
2021: 1 paper · 2022: none · 2023: 2 papers · 2024: 1 paper
Papers 4
- Early outcomes of MR-guided SBRT for patients with recurrent pancreatic adenocarcinoma. Co-author DOI 10.1186/s13014-024-02457-y↗
- Effect of a MUC5AC Antibody (NPC-1C) Administered With Second-Line Gemcitabine and Nab-Paclitaxel on the Survival of Patients With Advanced Pancreatic Ductal A… First author DOI 10.1001/jamanetworkopen.2022.49720↗
- Association of Pancreatic Adenocarcinoma Location With DNA Damage Response Status and Response to Platinum-Based Therapy. Last author DOI 10.1200/po.22.00648↗
- Multi-agent neoadjuvant chemotherapy improves survival in early-stage pancreatic cancer: A National Cancer Database analysis. Last author DOI 10.1016/j.ejca.2021.01.004↗
Closest collaborators
The 25 strongest of 25 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Charles J. Yeo · 3 shared papers, 2021–2024 · strength 0.49
- Paper Early outcomes of MR-guided SBRT for patients with recurrent pancreatic adenocarcinoma. DOI 10.1186/s13014-024-02457-y↗
- Paper Association of Pancreatic Adenocarcinoma Location With DNA Damage Response Status and Response to Platinum-Based Therap… DOI 10.1200/po.22.00648↗
- Paper Multi-agent neoadjuvant chemotherapy improves survival in early-stage pancreatic cancer: A National Cancer Database ana… DOI 10.1016/j.ejca.2021.01.004↗
- Harish Lavu · 2 shared papers, 2023–2024 · strength 0.34
- James A. Posey · 2 shared papers, 2021–2024 · strength 0.33
- Steven J. Cohen · 2 shared papers, 2021–2023 · strength 0.30
- Paper Association of Pancreatic Adenocarcinoma Location With DNA Damage Response Status and Response to Platinum-Based Therap… DOI 10.1200/po.22.00648↗
- Paper Multi-agent neoadjuvant chemotherapy improves survival in early-stage pancreatic cancer: A National Cancer Database ana… DOI 10.1016/j.ejca.2021.01.004↗
- Spencer Poiset · 1 shared paper, 2024 · strength 0.18
- Babar Bashir · 1 shared paper, 2024 · strength 0.18
- Adam Christopher Mueller · 1 shared paper, 2024 · strength 0.18
- Daniel Lin · 1 shared paper, 2024 · strength 0.18
- Emanuel F. Petricoin · 1 shared paper, 2023 · strength 0.15
- Ida Micaily · 1 shared paper, 2023 · strength 0.15
- Michael Jon Pishvaian · 1 shared paper, 2023 · strength 0.15
- Lynn McCormick Matrisian · 1 shared paper, 2023 · strength 0.15
- Aileen Deng · 1 shared paper, 2021 · strength 0.15
- Jordan Michael Winter · 1 shared paper, 2021 · strength 0.15
- Janet E. Murphy · 1 shared paper, 2023 · strength 0.15
- Philip Martin Arlen · 1 shared paper, 2023 · strength 0.15
- Hanna Kelly Sanoff · 1 shared paper, 2023 · strength 0.15
- Muhammad Shaalan Beg · 1 shared paper, 2023 · strength 0.15
- Peter J. Hosein · 1 shared paper, 2023 · strength 0.15
- Michael Andrew Morse · 1 shared paper, 2023 · strength 0.15
- Brian Matthew Wolpin · 1 shared paper, 2023 · strength 0.15
- Brandon M. Huffman · 1 shared paper, 2023 · strength 0.15
- Jill Lacy · 1 shared paper, 2023 · strength 0.15
- Andrea Wang‐Gillam · 1 shared paper, 2023 · strength 0.15
- James M. Cleary · 1 shared paper, 2023 · strength 0.15
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.